P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia
S. Calovi, Paula Mut-Arbona, Pál Tod, A. Iring, A. Nicke, S. Mato, E. Sylvester Vizi, J. Tønnesen, B. Sperlágh
Frontiers in Molecular Neuroscience November 11, 2020 DOI: 10.3389/fnmol.2020.566251 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experimental study Peer reviewed |
|---|---|
| Population | Young adult C57Bl/6J wild-type, P2X7R knockout (P2rx7−/−), and P2X7R-overexpressing (P2X7-EGFP) mice |
| Intervention | Phencyclidine (PCP) |
| Duration | 7 days subchronic systemic PCP treatment |
| Key findings | P2X7R expression level modulated schizophrenia-like positive and cognitive symptoms in PCP-based mouse models. P2X7R expression increased medial prefrontal cortex susceptibility to PCP-induced circuit hyperactivity, while knockout mice showed altered neuronal activation patterns, lower intrinsic excitability of mPFC neurons, and distinct microglial organization around hyperactive neurons. The authors propose a pleiotropic role for P2X7R in the mPFC. |
Abstract
Background: It has been consistently reported that the deficiency of the adenosine triphosphate (ATP) sensitive purinergic receptor P2X7 (P2X7R) ameliorates symptoms in animal models of brain diseases.
Objective: This study aimed to investigate the role of P2X7R in rodent models of acute and subchronic schizophrenia based on phencyclidine (PCP) delivery in animals lacking or overexpressing P2X7R, and to identify the underlying mechanisms involved.
Methods: The psychotomimetic effects of acute i.p. PCP administration in C57Bl/6J wild-type, P2X7R knockout (P2rx7−/−) and overexpressing (P2X7-EGFP) young adult mice were quantified. The medial prefrontal cortex (mPFC) of P2rx7−/− and heterozygous P2X7-EGFP acutely treated animals was characterized through immunohistochemical staining. The prefrontal cortices of young adult P2rx7−/− and P2rx7tg/+ mice were examined with tritiated dopamine release experiments and the functional properties of the mPFC pyramidal neurons in layer V from P2rx7−/− mice were assessed by patch-clamp recordings. P2rx7−/− animals were subjected to a 7 days subchronic systemic PCP treatment. The animals working memory performance and PFC cytokine levels were assessed.
Results: Our data strengthen the hypothesis that P2X7R modulates schizophrenia-like positive and cognitive symptoms in NMDA receptor antagonist models in a receptor expression level-dependent manner. P2X7R expression leads to higher medial PFC susceptibility to PCP-induced circuit hyperactivity. The mPFC of P2X7R knockout animals displayed distinct alterations in the neuronal activation pattern, microglial organization, specifically around hyperactive neurons, and were associated with lower intrinsic excitability of mPFC neurons.
Conclusions: P2X7R expression exacerbated PCP-related effects in C57Bl/6J mice. Our findings suggest a pleiotropic role of P2X7R in the mPFC, consistent with the observed behavioral phenotype, regulating basal dopamine concentration, layer-specific neuronal activation, intrinsic excitability of neurons in the mPFC, and the interaction of microglia with hyperactive neurons. Direct measurements of P2X7R activity concerning microglial ramifications and dynamics could help to further elucidate the molecular mechanisms involved.
Citations in the library
Cites 10
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats Science August 28, 1998
- Phencyclidine-induced head-weaving observed in mice after ritanserin treatment. European Journal of Pharmacology July 9, 1987
- Phencyclidine dose optimisation for induction of spatial learning and memory deficits related to schizophrenia in C57BL/6 mice. Experimental animals November 1, 2018
- Abnormal neural activation patterns underlying working memory impairment in chronic phencyclidine-treated mice. PLoS One 2017
and 5 more in the library